By Patrick Martin
January 3, 2021 – With its hospitals full to overflowing, UK authorities have opted for 1-dose mass vaccination for now.
The approved dosage for the BioTec/Pfizer and Moderna is 2 doses, 4 weeks apart.
However, such is the burden that patients are cared for in ambulances.
Winter has 3 or so more months to go.
In the circumstances, vaccine dosing recommendations have to be tweaked.
The 1-dose option provides many with something in short order.
Purists may balk. Trial data indicate 2 doses, 4 weeks apart is optimal – 95% efficacy.
Efficacy of the “1-dose for now” option is 50 – 60% which exceeds the established 50% threshold for moving forward.
UK authorities know cold chain and other logistics associated with the approved 2-dose regime are herculean to satisfactorily accomplish.
They know UK residents are sick and dying in higher numbers now.
UK residents need some protection, and they need it now.
Hands up for the “1-dose for now” option.
